fda warning letter glp-1 solution september 9 2025 Democratic lawmakers are pressing the Trump administration to disclose who received special access to Eli Lilly's investigational obesity drug retatrutide. Sen. Maggie Hassan (D-N.H.) sent a to HHS Secretary Robert F FDA issues 30 warning letters

Specific agents (liraglutide, semaglutide, dulaglutide) have demonstrated cardiovascular benefits in clinical trials

Missing meals, which results from significant appetite suppression, turns-off thyroid

64 A 90-day administration of dexamethasone (DEX) resulted in significant declines in both BMD and BMC, along with substantial increases in serum levels of glucose, insulin, triglycerides, total cholesterol, parathyroid hormone (PTH), osteoprotegerin (OPG), and bone resorption markers including deoxypyridinoline (DPD), N-terminal telopeptide of type I collagen (NTX-1), and TRAP-5b

These therapies have a central role in improving glycemic control and reducing cardiovascular risk

17, 2024, pp

Although we are lacking data on how many women were actually using the medication after redeeming their prescriptions in the preconceptual period, the results may indicate that women without diabetes who become pregnant while using these increasingly popular weight-loss medications have no increased risk of complications or preterm birth